Abstract

We have studied the possible interaction between three selective opioid-receptor antagonists, nor-binaltorphimine (NB: κ) (5 mg/kg), cyprodime (CY: μ) (10 mg/kg) and naltrindole (NTI: δ) (1 mg/kg), and the cannabinoid receptor agonist CP 55,940, in the modulation of anxiety (plus-maze) and adrenocortical activity (serum corticosterone levels by radioimmunoassay) in male rats. The holeboard was used to evaluate motor activity and directed exploration. CP 55,940 (75 μg/kg, but not 10 μg/kg) induced an anxiogenic-like effect, which was antagonised by NB. The other effects of CP 55,940 (75 μg/kg), a decreased holeboard activity and stimulation of adrenocortical activity, were not antagonised by any of the three opioid receptor antagonists. CY and NTI, when administered alone, induced marked reductions in motor activity, anxiogenic-like effects and stimulation of adrenocortical activity. The selective κ-opioid receptor antagonist NB, on its own, did not modify the level of anxiety but stimulated adrenocortical activity. We provide the first pharmacological evidence about the involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call